ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Teva axes Phase 3 trial into chronic cluster headache
pharmafile
June 22, 2018With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate further research into its calcitonin gene-related peptide (CGRP)
Pharma Sources Insight January 2025
